As time has gone, during these 20 years the CML/NF-κB relationship has become more mature and has offered different chances to investigate the contribution of this pathway in tumorigenesis and cancer therapy. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.